Form 4 for TARS Tarsus Pharmaceuticals, Inc.
Accepted 2026-03-24 00:00:00 ET · period of report 2026-03-20 · accession 0001827584-26-000011 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-24 | 2026-03-20 | TARS | Neervannan Seshadri | COO | S - Sale | $66.75 | -2,989 | 82.8K | -3% | -$199.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-20 | S | D | 2,989 | $66.75 | 82,791 | D | — | — |